COMMUNIQUÉS West-GlobeNewswire

-
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
24/01/2025 - 13:35 -
Director/PDMR Shareholding
24/01/2025 - 13:00 -
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
24/01/2025 - 13:00 -
Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
24/01/2025 - 11:19 -
Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference
24/01/2025 - 01:53 -
Dermatology Group of Arkansas Welcomes a New Registered Nurse
24/01/2025 - 01:04 -
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
24/01/2025 - 00:41 -
NADP Foundation Announces 2025 Grants to Advance Access to Oral Healthcare
23/01/2025 - 23:15 -
Impact BioMedical Inc. to Present at The Microcap Conference
23/01/2025 - 22:30 -
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
23/01/2025 - 22:05 -
Vincerx Pharma, Inc. Announces Reverse Stock Split
23/01/2025 - 22:05 -
Intuitive Announces Fourth Quarter Earnings
23/01/2025 - 22:05 -
Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia
23/01/2025 - 22:05 -
Grant of Restricted Stock Units and Warrants to Employees in Genmab
23/01/2025 - 21:08 -
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
23/01/2025 - 21:00 -
MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
23/01/2025 - 20:13 -
Vessl Prosthetics Secures Oversubscribed Pre-Seed Funding to Drive Innovation in Prosthetic Solutions
23/01/2025 - 19:00 -
America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
23/01/2025 - 18:00 -
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
23/01/2025 - 17:00
Pages